U.S. market Closed. Opens in 11 hours 39 minutes

CALA | Calithera Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
RevenueN/A9.75MN/AN/A22.25M25.95MN/AN/AN/AN/AN/A
Cost of Revenue1.39M1.43M1.87M1.84MN/AN/AN/AN/AN/AN/AN/A
Gross Profit-1.39M8.32M-1.87M-1.84M22.25MN/AN/AN/AN/AN/AN/A
Operating Expenses42.07M74.31M91.39M92.89M79.53M55.64M38.33M32.82M21.72MN/AN/A
Selling, General & Admin13.54M20.85M20.37M16.61M13.34M12.53M10.59M9.07M5.35M2.48M1.42M
Research & Development28.53M53.45M71.02M76.29M66.19M43.11M27.75M23.75M16.37M9.90M6.56M
Other Operating ExpensesN/A50.88MN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-42.07M-115.43M-91.39M-92.89M-57.28M-29.69M-38.33M-32.82M-21.72M-12.38M-7.97M
Other Expenses / Income2.42M345.00K1.25M3.04M2.65M1.86M330.00K175.00K9.00K1.00KN/A
Before Tax Income-39.65M-115.09M-90.14M-89.86M-54.63M-27.83M-38.00M-32.64M-21.71M-12.38M-7.97M
Income Tax Expenses-20.78M50.25M-1.61M-3.51M-3.16MN/AN/AN/AN/AN/AN/A
Net Income-18.87M-165.34M-88.52M-86.35M-51.47M-27.83M-38.00M-32.64M-21.71M-12.38M-7.97M
Interest Expenses-20.78MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding4.99M3.69M3.44M2.37M1.83M1.65M19.49M18.05M17.94M4.08M7.89M
Diluted Shares Outstanding4.99M3.69M3.44M2.37M1.83M1.65M19.49M18.05M17.94M4.08M7.89M
EBITDA-43.77M-13.68M-91.39M-92.89M-57.28M-27.46M-38.04M-32.41M-21.36M-12.10M-7.71M
EBITDA Margin0.00%-140.34%0.00%0.00%-257.40%-105.80%0.00%0.00%0.00%0.00%0.00%
EBIT-60.43M-115.09M-90.14M-89.86M-54.63M-27.83M-38.00M-32.64M-21.71M-12.38M-7.97M
EBIT Margin0.00%-1,180.39%0.00%0.00%-245.48%-107.21%0.00%0.00%0.00%0.00%0.00%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙